# Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.

> **NCT04914702** · — · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 20 (actual)

## Conditions studied

- Pediatric Cancer
- Febrile Neutropenia
- Oncology
- Chemotherapy-induced Neutropenia

## Interventions

- **DEVICE:** Everion®
- **DEVICE:** CORE®

## Key facts

- **NCT ID:** NCT04914702
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-16
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04914702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04914702, "Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04914702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*